Kaberuka calls for coordinated effort in the fight against AIDS
Donald Kaberuka, President of the African Development Bank (AfDB), is a member of the commission established under the aegis of the United Nations Programme on HIV/AIDS (UNAIDS) and the scientific journal The Lancet. As such, he took part in the latest series of consultations in London. On February 13, Kaberuka emphasized the importance of human capital in creating wealth and inclusive growth.
On February 13, Kaberuka emphasized the importance of human capital in creating wealth and inclusive growth. He also called for the international community, including multilateral development banks, to help build an enabling environment for improved fiscal policies and safety nets at the domestic level.
“If you want to build a self-sustaining economy, which ends poverty – ‘shared prosperity’, to use the words of my friend [World Bank President] Jim Kim – it takes more than money. International funding must leverage domestic responsibility,” Kaberuka said. “In our assessment, the time is right. Today, two-thirds of Sub-Saharan African countries will be growing at 6.2%.
“It could be that a particular country, for example, has oil, but has no public financial management systems, does not know how to do safety nets. I think all of us could go and help them to fix a well-functioning safety net. That is a good partnership, which I think could work.
“We need a partnership across institutions, including banks like ourselves, the World Bank and others,” Kaberuka continued. “We need more money from solidarity, from domestic resources, but we need to work smarter going forward.”
Launched in May 2013, “The UNAIDS and Lancet Commission: Defeating AIDS – Advancing global health” is co-chaired by Joyce Banda, President of the Republic of Malawi, with Nkosazana Dlamini Zuma, African Union Commission Chairperson, and Peter Piot, Director of the London School of Hygiene and Tropical Medicine (LSHTM).
The first series of consultations was held in Malawi in June 2013. This second series took place in the UK capital on February 13 and 14, 2014 and is expected to result in a major report to be published shortly in the medical journal The Lancet.